Key informant views on potential acceptability and feasibility of long-acting antiretroviral treatment for HIV in Kenya
Abstract Background In 2020, 14% of diagnosed persons living with HIV (PLWH) in Kenya were not taking antiretroviral therapy (ART), and 19% of those on ART had unsuppressed viral loads. Long-acting antiretroviral therapy (LA-ART) may increase viral suppression by promoting ART uptake and adherence....
Main Authors: | Anne Kaggiah, Catherine N. Maina, John Kinuthia, Douglas Barthold, Brett Hauber, Jacinda Tran, Jane M. Simoni, Susan M. Graham |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-04-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-024-09309-w |
Similar Items
-
Perceived benefits and barriers to the use of long-acting injectable antiretroviral treatment among adolescents and young people living with HIV in Western Kenya: qualitative findings from the KuwaFree! LiveFree! Study
by: Shukri A. Hassan, et al.
Published: (2025-03-01) -
Preferences for and acceptability of long-acting HIV prevention products among pregnant and lactating women accessing health services in Kenya: a mixed method cross-sectional analysis
by: Vallery Ogello, et al.
Published: (2025-01-01) -
Patient preferences for long-acting HIV treatment: a preference heterogeneity assessment
by: Enrique M. Saldarriaga, et al.
Published: (2025-02-01) -
Preferences and acceptability for long‐acting PrEP agents among pregnant and postpartum women with experience using daily oral PrEP in South Africa and Kenya
by: Nafisa J. Wara, et al.
Published: (2023-05-01) -
Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central Kenya
by: P. Wekesa, et al.
Published: (2022-06-01)